Published in J Virol on November 01, 1973
Definitive evidence that the murine C-type virus inducing locus Akv-1 is viral genetic material. Proc Natl Acad Sci U S A (1975) 3.51
Autogenous immunity to endogenous RNA tumor virus. Identification of antibody reactivity to select viral antigens. J Exp Med (1974) 2.10
Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proc Natl Acad Sci U S A (1974) 1.54
Relationship of infectious murine leukemia virus and virus-related antigens in genetic crosses between AKR and the Fv-1 compatible strain C57L. J Exp Med (1976) 1.18
Plaque assay techniques for murine leukemia viruses. Virology (1970) 29.21
A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses. J Exp Med (1971) 9.81
Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1 n strains of mice. J Exp Med (1972) 6.52
Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. J Exp Med (1966) 6.45
The G (Gross) leukemia antigen. Cancer Res (1965) 6.07
The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. J Exp Med (1971) 6.06
A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus. J Exp Med (1971) 5.50
Improved complementation in the cytotoxic test. Transplantation (1970) 3.93
Current enigmas in cancer research. Harvey Lect (1973) 3.91
Genetic mapping of a murine leukemia virus-inducing locus of AKR mice. Science (1972) 3.81
Studies of genetic transmission of murine leukemia virus by AKR mice. II. Crosses with Fv-1 b strains of mice. J Exp Med (1972) 3.47
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77
Segregation of loci for C-type virus induction in strains of mice with high and low incidence of leukemia. Science (1973) 2.17
A genetic locus for inducibility of C-type in BALB-c cells: the effect of a nonlinked regulatory gene on detection of virus after chemical activation. Proc Natl Acad Sci U S A (1972) 1.97
Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor viruses. Proc Natl Acad Sci U S A (1971) 1.86
Separation of RNA-dependent DNA polymerase activity from the murine leukaemia virion. Nature (1970) 1.80
Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection. J Natl Cancer Inst (1968) 1.79
Genetic mapping of the Fv-1 lcous of the mouse. Science (1973) 1.75
A major genetic locus affecting resistance to infection with murine leukemia viruses. 3. Assignment of the Fv-1 locus to linkage group 8 of the mouse. J Exp Med (1973) 1.68
Serological analysis of cell surface antigens of tumors induced by murine leukemia virus. J Natl Cancer Inst (1972) 1.29
Relation of chromosome 4 (linkage group 8) to murine leukemia virus-associated antigens of AKR mice. J Exp Med (1973) 1.27
Location of the second gene required for expression of the leukemia-associated mouse antigens G IX . Science (1972) 1.26
Genetic control of the group-specific antigen of murine leukaemia virus. Nat New Biol (1973) 0.86
Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Serological classification of Neisseria gonorrhoeae with monoclonal antibodies. Infect Immun (1982) 5.54
Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis (1984) 5.40
A proposed nomenclature for the virion proteins of oncogenic RNA viruses. Virology (1974) 5.01
The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses. Virology (1979) 4.59
Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence. Cancer Res (1972) 3.23
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med (1981) 3.06
The use of fibrin sealant in the prevention of seromas. Plast Reconstr Surg (1997) 2.97
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p 15(E) and gp70 envelope proteins. Virology (1979) 2.62
Monoclonal antibodies to herpes simplex viruses: use in antigenic typing and rapid diagnosis. J Infect Dis (1983) 2.60
Typing of clinical herpes simplex virus isolates with mouse monoclonal antibodies to herpes simplex virus types 1 and 2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA. J Clin Microbiol (1983) 2.50
Transcription of mouse mammary tumor virus genes in tissues from high and low tumor incidence mouse strains. J Mol Biol (1973) 2.45
Oncogenicity of AKR endogenous leukemia viruses. J Virol (1978) 2.31
Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus. Virology (1968) 2.26
Common properties of the oncogenic RNA viruses (oncornaviruses). Virology (1970) 2.20
Monoclonal antibodies for diagnosis of infectious diseases in humans. Science (1983) 2.02
Antibody to leukemia virus: widespread occurrence in inbred mice. Science (1974) 1.91
Mammary tumour virus specific nucleotide sequences in mouse DNA. Nat New Biol (1972) 1.87
Endogenous ecotropic mouse type C viruses deficient in replication and production of XC plaques. J Virol (1976) 1.87
Characterization of monoclonal antibodies to Treponema pallidum. J Immunol (1985) 1.83
Serological analysis of the deoxyribonucleic acid polymerase of avian oncornaviruses. II. Comparison of avian deoxyribonucleic acid polymerases. J Virol (1972) 1.75
Oncornaviruses produced by murine leukemia cells in culture. Virology (1977) 1.73
Topological mapping of murine leukemia virus proteins by competition-binding assays with monoclonal antibodies. Virology (1980) 1.72
Viral proteins expressed on the surface of murine leukemia cells. J Virol (1977) 1.60
Endogenous oncornaviruses in chemically induced transformation. I. Transformation independent of virus production. Virology (1975) 1.55
Identification of the Gross cell surface antigen associated with murine leukemia virus-infected cells. J Virol (1977) 1.54
Helical nucleocapsid structure of the oncogenic ribonucleic acid viruses (oncornaviruses). J Virol (1971) 1.48
A new human T-cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells. Immunogenetics (1980) 1.43
Serological and structural properties of Mason-Pfizer monkey virus isolated from the mammary tumor of a Rhesus monkey. Proc Natl Acad Sci U S A (1971) 1.43
Successful treatment of fungal prosthetic valve endocarditis: case report and review. Clin Infect Dis (1996) 1.42
Monoclonal antibodies recognizing normal human T lymphocytes and malignant human B lymphocytes: a comparative study. J Immunol (1981) 1.41
Antibody response of mice to chemically induced tumors. Proc Natl Acad Sci U S A (1978) 1.41
Biosynthesis and metabolism of viral proteins expressed on the surface of murine leukemia virus-infected cells. Virology (1978) 1.39
Purification of IMP:pyrophosphate phosphoribosyltransferases, catalytically incompetent enzymes in Lesch-Nyhan disease. Proc Natl Acad Sci U S A (1971) 1.36
Anomalous reactions of mouse alloantisera with cultured tumor cells. II. Cytotoxicity is caused by antibodies to leukemia viruses. J Immunol (1975) 1.34
Immune response of the mouse to the major core protein (p30) of ecotropic leukemia viruses. J Immunol (1976) 1.31
Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen. Science (1980) 1.30
Specific in vivo localization of monoclonal antibodies directed against the Thy 1.1 antigen. J Immunol (1980) 1.29
Serological identification of hamster oncornaviruses. Nat New Biol (1971) 1.26
Immune response in the mouse to endogenous leukemia viruses. Cold Spring Harb Symp Quant Biol (1975) 1.22
Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2). J Exp Med (1979) 1.21
Lysis of leukemia cells by spleen cells of normal mice. Proc Natl Acad Sci U S A (1975) 1.20
Characteristics of the structural components of the mouse mammary tumor virus. I. Morphological and biochemical studies. Virology (1971) 1.18
Structure of retroviral RNAs produced by cell lines derived from spontaneous lymphomas of AKR mice. J Virol (1982) 1.12
A soluble antigen of the mammary tumor virus. Virology (1967) 1.07
Presence of T cell-associated surface antigens on murine NK cells. J Immunol (1979) 1.03
Selective neutralization of ecotropic murine leukemia virus by monoclonal antibodies: localization of a site on the gp70 protein associated with ecotropism. Virology (1981) 1.03
Cellular changes in the thymuses of preleukemic AKR mice: correlation with changes in the expression of murine leukemia viruses. Cell (1977) 1.03
The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens. J Exp Med (1979) 1.03
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. III. Avian viral proteins with group-specific antigenicity. Virology (1975) 1.01
Genetic and viral factors influencing the development of spontaneous leukemia in AKR mice. Virology (1979) 0.99
Alteration of lymphoid cells in AKR mice by treatment with monoclonal antibody against Thy-1 antigen. Transplantation (1982) 0.99
Serological analysis of antigenic determinants on the env gene products of AKR dualtropic (MCF) murine leukemia viruses. Virology (1980) 0.99
Monoclonal antibodies identify individual determinants on mouse mammary tumor virus glycoprotein gp52 with group, class, or type specificity. J Virol (1980) 0.98
Lysis of retroviruses with monoclonal antibodies against viral envelope proteins. Virology (1980) 0.96
Genetic control of natural immunity to ecotropic mouse leukemia viruses: immune response genes. Infect Immun (1976) 0.95
Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. J Immunol (1980) 0.93
Control of nosocomial multiresistant Enterobacteriaceae using a temporary restrictive antibiotic agent policy. Eur J Clin Microbiol Infect Dis (2001) 0.93
Polymorphism in the major core protein (p30) of murine leukemia viruses as identified by mouse antisera. Virology (1978) 0.91
Monoclonal antibodies recognizing human T cells: potential role for preventing graft-versus-host reactions following allogeneic marrow transplantation. Transplant Proc (1981) 0.91
Identification of an FMR cell surface antigen associated with murine leukemia virus-infected cells. J Virol (1978) 0.91
Founder's Award, Society for Biomaterials. Sixth World Biomaterials Congress 2000, Kamuela, HI,May 15-20, 2000. Really smart bioconjugates of smart polymers and receptor proteins. J Biomed Mater Res (2000) 0.90
Genetic control of natural immunity to ecotropic mouse leukemia viruses: production of endogenous immunogen. Infect Immun (1976) 0.89
Phase-separation immunoassays. Clin Chem (1987) 0.89
Amplified expression of murine leukemia virus (MuLV)-coded antigens on thymocytes and leukemia cells of AKR mice after infection by dualtropic (MCF) MuLV. Virology (1982) 0.87
Identification of Ly-5 and T200 antigens on identical cell surface proteins. J Immunol (1980) 0.87
The role of viral and cell-associated antigens in the cell-mediated immune response of rats to virus-induced lymphoma cells. J Immunol (1980) 0.81
Detection of polymorphism in BALB/c leukemia viruses with mouse antisera. J Virol (1979) 0.81
Cytotoxic activities of monoclonal antibodies against the envelope proteins of murine leukemia virus. Cancer Res (1980) 0.81
Cell-specific cytotoxicity expressed by a conjugate of ricin and murine monoclonal antibody directed against thy 1.1 antigen. Cancer Res (1981) 0.81
Harvesting of the latissimus dorsi muscle: a small animal model for seroma formation. Microsurgery (1995) 0.79
Immunological studies on mouse mammary tumors. VI. Further characterization of a mammary tumor antigen and its distribution in lymphatic cells of allogeneic mice. Int J Cancer (1972) 0.79
Antibody to murine leukemia virus: genetic control linked to the H-2 locus in PL mice. J Immunol (1976) 0.78
Influence of mammary tumor virus infection on the acceptance or rejection of transplanted ML+ leukemias. Proc Soc Exp Biol Med (1968) 0.78
Serological and biochemical analysis of the PlA1 alloantigen of human platelets. Br J Haematol (1982) 0.78
Monoclonal mouse antibodies as probes for antigenic polymorphism in murine leukemia viruses. Virology (1979) 0.78
In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol (1993) 0.77
Application of a thermally-reversible polymer-antibody conjugate in a novel membrane-based immunoassay. Biochem Biophys Res Commun (1990) 0.77
The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo. Adv Perit Dial (1991) 0.76
Antibodies to the envelope protein (gp70) of endogenous xenotropic and ecotropic leukemia viruses: induction by immunization with leukemia cells. Virology (1979) 0.76
Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int (1992) 0.75
Vaccine reactions. Nat Med (1998) 0.75
Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo. Adv Perit Dial (1991) 0.75
Decreased immunity to viral antigens and increased expression of endogenous leukemia viruses in athymic (nude) mice. Virology (1977) 0.75
Serologic and structural studies of mouse mammary tumor virus. J Natl Cancer Inst (1972) 0.75
Endogenous oncornaviruses in chemically induced transformation. II. Effect of virus production in vivo. J Natl Cancer Inst (1976) 0.75
Monoclonal antibody directed to the stage-specific embryonic antigen (SSEA-1) reacts with branched glycosphingolipid similar in structure to Ii antigen. Biochem Biophys Res Commun (1980) 0.75
Thy-2: a murine thymocyte-brain alloantigen controlled by a gene linked to the major histocompatibility complex. Immunogenetics (1981) 0.75